As the intragastric concentration of G. elata total RNA increased in the low/medium/high-dose groups, a corresponding decrease was noted in intracerebral GSK-3β levels among AD mice, accompanied by significant reductions in Tau protein phosphorylation levels at the Thr181 and Ser396 sites. The gene discussed is MAPT; the disease is Alzheimer disease.